Related Experiment Video
Updated: Dec 7, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and
E Jennifer Edelman1, James Dziura2, Denise Esserman3
1Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States of America; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, United States of America.
Implementation Facilitation (IF) improved addiction treatment delivery in HIV clinics. This strategy addresses substance misuse in people with HIV (PWH), enhancing care and clinical outcomes.
Area of Science:
- Implementation Science
- Public Health
- Addiction Medicine
Background:
- Substance misuse (tobacco, alcohol, opioids) significantly impacts morbidity and mortality in people with HIV (PWH).
- Evidence-based addiction treatments are underutilized in HIV clinics, posing a care gap.
- The Working with HIV clinics to adopt Addiction Treatment using Implementation Facilitation (WHAT-IF?) study addresses this implementation challenge.
Purpose of the Study:
- To conduct a formative evaluation of barriers and facilitators to implementing addiction treatment in HIV clinics.
- To evaluate the impact of Implementation Facilitation (IF) on the adoption of addiction treatments.
- To assess the effect of IF on clinical outcomes for PWH receiving addiction treatment.
Main Methods:
- Hybrid type 3 effectiveness-implementation stepped wedge design across four Northeast US HIV clinics.
- Guided by the Promoting Action on Research Implementation in Health Services Research (PARiHS) framework.
- Mixed-methods approach to identify barriers/facilitators and tailor IF, followed by evaluation of IF's impact on implementation and effectiveness outcomes.
Main Results:
- Implementation Facilitation (IF) was evaluated for its impact on the provision of addiction treatment (primary outcome).
- Assessed organizational and clinician readiness for adopting addiction treatment and changes in care delivery models.
- Examined IF's effect on HIV-related outcomes among patients eligible for addiction treatment.
Conclusions:
- Results will provide crucial information on the impact of IF as a reproducible strategy.
- Demonstrates the potential of IF to enhance addiction treatment integration within HIV care settings.
- Highlights IF's role in improving both implementation and effectiveness outcomes for PWH with substance use disorders.
More Related Videos
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Therapeutic Drug Monitoring: Affecting Factors
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Retrovirus Life Cycles

